126 related articles for article (PubMed ID: 1804424)
21. Neuroendocrine tumors of the ovary--a review.
Kupryjańczyk J
Verh Dtsch Ges Pathol; 1997; 81():253-9. PubMed ID: 9474878
[TBL] [Abstract][Full Text] [Related]
22. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.
Goldstein NS; Uzieblo A
Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727
[TBL] [Abstract][Full Text] [Related]
23. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
24. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
25. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical demonstration of chromogranin in endometrial carcinomas with argyrophil cells.
Inoue M; Delellis RA; Scully RE
Hum Pathol; 1986 Aug; 17(8):841-7. PubMed ID: 3525382
[TBL] [Abstract][Full Text] [Related]
27. [Neuroendocrine differentiation in ovarian mucinous tumors].
Jiang C; Tan Y; Li E
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):130-3. PubMed ID: 11244965
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis.
Määttä M; Bützow R; Luostarinen J; Petäjäniemi N; Pihlajaniemi T; Salo S; Miyazaki K; Autio-Harmainen H; Virtanen I
J Histochem Cytochem; 2005 Oct; 53(10):1293-300. PubMed ID: 15923364
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A immunoreactivity and Grimelius' argyrophilia. A correlative study in mammalian endocrine cells.
Cetin Y
Anat Embryol (Berl); 1992; 185(3):207-15. PubMed ID: 1349463
[TBL] [Abstract][Full Text] [Related]
30. [Ultrastructural characteristics of endometrioid and serous ovarian adenocarcinomas].
Kolosov AE; Chernina LA; Bychkov VM
Arkh Patol; 1983; 45(8):34-8. PubMed ID: 6639391
[TBL] [Abstract][Full Text] [Related]
31. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
[TBL] [Abstract][Full Text] [Related]
33. Goblet cell carcinoid of the vermiform appendix with ovarian metastasis mimicking mucinous cystadenocarcinoma.
Ikeda E; Tsutsumi Y; Yoshida H; Yanagi K
Acta Pathol Jpn; 1991 Jun; 41(6):455-60. PubMed ID: 1950561
[TBL] [Abstract][Full Text] [Related]
34. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.
Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G
Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for benign serous and mucinous epithelial ovarian tumors.
Jordan SJ; Green AC; Whiteman DC; Webb PM
Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
[TBL] [Abstract][Full Text] [Related]
37. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls.
Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777
[TBL] [Abstract][Full Text] [Related]
38. Histologic subtypes and laterality of primary epithelial ovarian tumors.
Boger-Megiddo I; Weiss NS
Gynecol Oncol; 2005 Apr; 97(1):80-3. PubMed ID: 15790441
[TBL] [Abstract][Full Text] [Related]
39. Mucinous tumors of the ovary with argyrophil cells. An immunohistochemical analysis.
Aguirre P; Scully RE; Dayal Y; DeLellis RA
Am J Surg Pathol; 1984 May; 8(5):345-56. PubMed ID: 6203413
[TBL] [Abstract][Full Text] [Related]
40. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
Scully RE
Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
